Literature DB >> 19190264

Amino acid-sensing mTOR signaling is involved in modulation of lipolysis by chronic insulin treatment in adipocytes.

Chongben Zhang1, Mee-Sup Yoon, Jie Chen.   

Abstract

Chronically high insulin levels and increased circulating free fatty acids released from adipose tissue through lipolysis are two features associated with insulin resistance. The relationship between chronic insulin exposure and adipocyte lipolysis has been unclear. In the present study we found that chronic insulin exposure in 3T3-L1 adipocytes, as well as in mouse primary adipocytes, increased basal lipolysis rates. This effect of insulin on lipolysis was only observed when the mammalian target of rapamycin (mTOR) pathway was inhibited by rapamycin in the adipocytes. In addition, amino acid deprivation in adipocytes phenocopied the effect of rapamycin in permitting the stimulation of lipolysis by chronic insulin exposure. The phosphatidylinositol 3-kinase-Akt pathway does not appear to be involved in this insulin effect. Furthermore, we found that triacylglycerol hydrolase (TGH) activity was required for the stimulation of lipolysis by combined exposure to insulin and rapamycin. Therefore, we propose that nutrient sufficiency, mediated by an mTOR pathway, suppresses TGH-dependent lipolysis stimulated by chronic insulin exposure in adipocytes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19190264      PMCID: PMC2670623          DOI: 10.1152/ajpendo.90651.2008

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  45 in total

Review 1.  Cellular mechanisms of insulin resistance.

Authors:  G I Shulman
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

Review 2.  Resistin, obesity, and insulin resistance--the emerging role of the adipocyte as an endocrine organ.

Authors:  A R Shuldiner; R Yang; D W Gong
Journal:  N Engl J Med       Date:  2001-11-01       Impact factor: 91.245

Review 3.  Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome.

Authors:  B L Wajchenberg
Journal:  Endocr Rev       Date:  2000-12       Impact factor: 19.871

4.  Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells.

Authors:  F Tremblay; A Marette
Journal:  J Biol Chem       Date:  2001-08-09       Impact factor: 5.157

5.  Lipolysis in the absence of hormone-sensitive lipase: evidence for a common mechanism regulating distinct lipases.

Authors:  Hiroaki Okazaki; Jun-Ichi Osuga; Yoshiaki Tamura; Naoya Yahagi; Sachiko Tomita; Futoshi Shionoiri; Yoko Iizuka; Ken Ohashi; Kenji Harada; Satoshi Kimura; Takanari Gotoda; Hitoshi Shimano; Nobuhiro Yamada; Shun Ishibashi
Journal:  Diabetes       Date:  2002-12       Impact factor: 9.461

6.  Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients.

Authors:  Joel D Morrisett; Ghada Abdel-Fattah; Ron Hoogeveen; Eddie Mitchell; Christie M Ballantyne; Henry J Pownall; Antone R Opekun; Jonathon S Jaffe; Suzanne Oppermann; Barry D Kahan
Journal:  J Lipid Res       Date:  2002-08       Impact factor: 5.922

Review 7.  Hormone-sensitive lipase: control of intracellular tri-(di-)acylglycerol and cholesteryl ester hydrolysis.

Authors:  Fredric B Kraemer; Wen-Jun Shen
Journal:  J Lipid Res       Date:  2002-10       Impact factor: 5.922

8.  Sirolimus changes lipid concentrations and lipoprotein metabolism in kidney transplant recipients.

Authors:  J D Morrisett; G Abdel-Fattah; B D Kahan
Journal:  Transplant Proc       Date:  2003-05       Impact factor: 1.066

9.  Rapamycin partially prevents insulin resistance induced by chronic insulin treatment.

Authors:  Cathleen E Berg; Brian E Lavan; Cristina M Rondinone
Journal:  Biochem Biophys Res Commun       Date:  2002-05-10       Impact factor: 3.575

10.  Beta -Arrestin 1 down-regulation after insulin treatment is associated with supersensitization of beta 2 adrenergic receptor Galpha s signaling in 3T3-L1 adipocytes.

Authors:  Christopher J Hupfeld; Stephane Dalle; Jerrold M Olefsky
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-30       Impact factor: 11.205

View more
  6 in total

Review 1.  The multifaceted role of mTORC1 in the control of lipid metabolism.

Authors:  Stéphane J H Ricoult; Brendan D Manning
Journal:  EMBO Rep       Date:  2012-02-12       Impact factor: 8.807

2.  Hepatitis C virus core protein decreases lipid droplet turnover: a mechanism for core-induced steatosis.

Authors:  Charles Harris; Eva Herker; Robert V Farese; Melanie Ott
Journal:  J Biol Chem       Date:  2011-10-07       Impact factor: 5.157

3.  Oncogenic PI3K and K-Ras stimulate de novo lipid synthesis through mTORC1 and SREBP.

Authors:  S J H Ricoult; J L Yecies; I Ben-Sahra; B D Manning
Journal:  Oncogene       Date:  2015-06-01       Impact factor: 9.867

Review 4.  mTORC1 signaling and the metabolic control of cell growth.

Authors:  Issam Ben-Sahra; Brendan D Manning
Journal:  Curr Opin Cell Biol       Date:  2017-04-12       Impact factor: 8.382

5.  Chronic leucine supplementation improves glycemic control in etiologically distinct mouse models of obesity and diabetes mellitus.

Authors:  Kaiying Guo; Yi-Hao Yu; Jue Hou; Yiying Zhang
Journal:  Nutr Metab (Lond)       Date:  2010-07-12       Impact factor: 4.169

Review 6.  The Role of Mammalian Target of Rapamycin (mTOR) in Insulin Signaling.

Authors:  Mee-Sup Yoon
Journal:  Nutrients       Date:  2017-10-27       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.